A Safety and Efficacy Study to Evaluate Rosacea

NCT03883945 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor deprioritization

Conditions

Papulopustular Rosacea

Interventions

DRUG: AIV001
DRUG: Vehicle

Sponsor

AiViva BioPharma, Inc.